The Benaroya Research Institute (BRI) in Seattle, WA seeks to recruit several outstanding investigators for new faculty positions at the assistant or associate member level, equivalent to assistant or associate professor. We seek candidates who use innovative experimental and/or computational approaches to study immune system function in health and disease, with a particular emphasis on autoimmune and immune-mediated diseases. We particularly encourage investigators in the following areas to apply: B cell biology, tissue immunity, innate immunity, systems immunology, and stromal-immune interactions. However, candidates from all areas of immunology will be considered.
These positions offer an opportunity to join a non-profit research institute with expertise in fundamental and translational immunology uniquely focused on immune-mediated diseases with a highly interactive and collaborative environment. The Benaroya Research Institute has outstanding, cutting edge core facilities to support a broad range of immunology research, including human sample biorepositories with healthy control and disease samples, genomics, flow cytometry, microscopy, histology and animal use cores. As part of the Seattle research community, BRI benefits from a rich and collaborative academic environment, with multiple major universities, research institutions, hospitals, and industry partners in close proximity. BRI offers highly attractive start-up packages and a scientific environment that supports junior faculty through extensive mentoring. Many BRI faculty have appointments as affiliate faculty in departments at the University of Washington. For physician scientist applicants, clinical time can be requested at our partner Virginia Mason Medical Center, with particular interest in Allergy/Immunology, Dermatology, Gastroenterology, Neurology, Pathology, Pulmonary, and Rheumatology related research.
BRI is devoted to finding causes and cures for immune system diseases and is an international leader in translating discoveries in autoimmune diseases to real life applications. Research at BRI encompasses many approaches, from studies of fundamental immunology processes, genetics and translational immunology, to clinical trials. BRI is powered by excellent laboratory facilities, an extensive biorepository of samples from autoimmune patients and healthy subjects, and houses two international clinical research networks, the Immune Tolerance Network and Type 1 Diabetes TrialNet. Read more about BRI and our research at www.benaroyaresearch.org.
